Dimension Bio
Biotechnology company developing 3D-printed therapeutics for organ regeneration, including bone grafts and treatments for end-stage liver failure, using hyperelastic materials technology.
Notes
Dimension Bio (formerly Dimension Inx) is a biotechnology company based in Chicago developing 3D-printed therapeutics for organ regeneration. The company was spun out of Northwestern University based on research in hyperelastic materials and 3D printing technology.
Dimension Bio's technology enables the creation of 3D-printed implants that can regenerate damaged tissue. The company's initial focus areas include bone grafts and treatments for end-stage liver failure, with their bone graft product having received FDA 510(k) clearance.
The company is part of the Portal Innovations portfolio, a venture creation firm focused on life sciences companies emerging from academic research.
Team
- Caralynn Nowinski Collens - Founder & CEO
- Ramille Shah, Ph.D. - Co-founder (Northwestern University Professor)
- Adam Jakus, Ph.D. - Co-founder
Additional Research Findings
- Portfolio company of Portal Innovations
- University Spinout: Northwestern University
- Stage: Clinical; 510(k) FDA clearance for bone graft product
- Focus on 3D printing for organ regeneration
- Hyperelastic materials technology
- Target applications: bone grafts, liver failure treatment
- Based in Chicago, Illinois
- Originally founded as Dimension Inx
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Portal Innovations | US | biotech-focused | - | 13 |